Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein

US Patent 6592872 · Granted Jul 15, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses2025
Purification and labeling of extracellular vesicles using a mixed mode resin com2024
Molecular nanotags2022
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Optical configuration methods for spectral scatter flow cytometry2020
Modified anthrax toxin protective antigen2020
Optical device and method for wheel alignment2019
Effective defect management across multiple code branches2019
Multi-epitope TARP peptide vaccine and uses thereof2019
Antibodies to tumor endothelial marker 82019
Protease-deficient bacillus anthracis2019
Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin2019